02:57:22 EDT Mon 27 May 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:OPS from 2023-05-28 to 2024-05-27 - 19 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2023-12-12 20:53C:OPSOpsens Inc2.90Shares Delisted from TSXOpsens to be delisted from TSX Dec. 13
2023-12-12 10:25C:OPSOpsens Inc2.895News ReleaseOpsens acquired by Haemonetics
2023-12-08 09:45C:OPSOpsens Inc2.89News ReleaseOpsens to complete Haemonetics transaction Dec. 12
2023-12-01 14:22C:OPSOpsens Inc2.88News ReleaseOpsens shareholders approve Haemonetics deal
2023-11-28 10:24C:OPSOpsens Inc2.88News ReleaseOpsens receives regulatory nod for Haemonetics deal
2023-11-22 12:52C:OPSOpsens Inc2.85SEDAR MD & ASEDAR MD & A
2023-11-22 12:51C:OPSOpsens Inc2.85SEDAR MD & ASEDAR MD & A
2023-11-22 12:36C:OPSOpsens Inc2.85SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-11-22 12:33C:OPSOpsens Inc2.85SEDAR Annual Information FormSEDAR Annual Information Form
2023-11-22 11:35C:OPSOpsens Inc2.85News ReleaseOpsens loses $12.4-million in fiscal 2023
2023-11-13 10:38C:OPSOpsens Inc2.84News ReleaseOpsens takeover by Haemonetics receives ISS nod
2023-11-02 10:34C:OPSOpsens Inc2.85News ReleaseOpsens receives interim court order re Haemonetics deal
2023-10-23 14:34C:OPSOpsens Inc2.845News ReleaseOpsens reviews SAFE-TAVI clinical study results
2023-10-11 08:29C:OPSOpsens Inc2.83In the NewsGlobe says Opsens accepts $345-million offer
2023-10-10 09:29C:OPSOpsens Inc2.83News ReleaseOpsens to be acquired by Haemonetics
2023-07-13 10:16C:OPSOpsens Inc1.67SEDAR MD & ASEDAR MD & A
2023-07-13 10:15C:OPSOpsens Inc1.67SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-13 09:45C:OPSOpsens Inc1.67News ReleaseOpsens loses $4.15-million in Q3 2023
2023-07-06 13:29C:OPSOpsens Inc1.60News ReleaseOpsens to release Q3 2023 results July 13